1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Central Nervous System Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chu, T; Gao, Z; Liu, Y; Shields, CB; Shields, LBE; Wang, Y; Zhang, YP; Zhu, Q | 1 |
| Baek, S; Chang, HW; Kim, H; Kim, M; Kwon, S; Lee, K; Moon, T | 1 |
| Feuerstein, GZ; Frerichs, KU | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Central Nervous System Diseases
| Article | Year |
|---|---|
Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.
Topics: Animals; Blood Platelets; Central Nervous System Diseases; Humans; Inflammation; Neurons; Platelet Activating Factor; Signal Transduction | 2017 |
Platelet-activating factor--key mediator in neuroinjury?
Topics: Brain; Central Nervous System Diseases; Humans; Platelet Activating Factor | 1990 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Central Nervous System Diseases
| Article | Year |
|---|---|
Platelet-activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Age Factors; Central Nervous System Diseases; Child; Child, Preschool; Female; Humans; Infant, Newborn; Male; Phospholipases A; Platelet Activating Factor | 2002 |